| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 09/27/2007 | CA2646227A1 Substituted 1-amino-4-phenyl-dihydroisoquinolines, method for the production thereof, use thereof as a medicament, and medicaments containing them |
| 09/27/2007 | CA2645583A1 Methods of inhibiting btk and syk protein kinases |
| 09/26/2007 | EP1837330A1 Benzamide inhibitors of the P2X7 receptor |
| 09/26/2007 | EP1837035A1 Therapeutic agent for chronic obstructive pulmonary disease (copd), cystic fibrosis or pulmonary hypertension |
| 09/26/2007 | EP1837021A2 Inhalative solution formulation containing a tiotropium salt |
| 09/26/2007 | EP1836226A1 Antibodies against il-13 receptor alpha 1 and uses thereof |
| 09/26/2007 | EP1490364B1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders |
| 09/26/2007 | EP1451153B1 Nk1 antagonists |
| 09/26/2007 | EP1417173B1 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 09/26/2007 | EP1417055A4 Use of copper chelators to inhibit the inactivation of protein c |
| 09/26/2007 | EP1414825B1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/26/2007 | EP1409740B1 Asthma-associated gene |
| 09/26/2007 | EP1383750B1 Urea derivatives as integrin alpha 4 antagonists |
| 09/26/2007 | EP1358181B1 Substituted pyrrolidines as ccr-3 receptor antagonists |
| 09/26/2007 | EP1322673B1 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 09/26/2007 | EP1307187B1 Use of 13-cis retinoic acid for the treatment of emphysema |
| 09/26/2007 | EP1261585B1 Substituted indole mannich bases |
| 09/26/2007 | EP1228046B1 Phthalazinone derivatives as pde 4 inhibitors |
| 09/26/2007 | EP1163910B1 Rho kinase inhibitors for the prevention or treatment of interstitial pneumonia and pulmonary fibrosis |
| 09/26/2007 | CN101043904A Nutritional composition comprising indigestible oligosaccharides |
| 09/26/2007 | CN101043881A The treatment of inflammatory disorders and pain |
| 09/26/2007 | CN101041049A Chinese traditional medicine compound took orally for treating chronic bronchitis |
| 09/26/2007 | CN101041009A Chinese traditional medicine compound for treating faucitis |
| 09/26/2007 | CN101041002A Chinese medicinal composition took orally for treating nasosinusitis |
| 09/26/2007 | CN101041001A Medicine for treating cough and asthma and removing phlegm and the method for preparing the oral liquid thereof |
| 09/26/2007 | CN101041000A Medicine compound for treating snoring and the preparing method and the quality control method |
| 09/26/2007 | CN101040999A Medicine compound for treating snoring and the preparing method and the quality control method |
| 09/26/2007 | CN101040998A Mint and reed root beverage for reducing fever |
| 09/26/2007 | CN101040996A Food for curing bronchial asthma |
| 09/26/2007 | CN101040973A Baiguo oral liquor for treating asthma |
| 09/26/2007 | CN101040967A Mongol medicine for treating respiratory inflammation |
| 09/26/2007 | CN101040958A Medical function of fresh rehmannia root juice for treating and preventing allergic diseases |
| 09/26/2007 | CN101040951A Method of controlling the quality of Ynxingchao dropping pills compound |
| 09/26/2007 | CN101040950A Method of preparing Ynxingchao dropping pills compound |
| 09/26/2007 | CN101040942A Active ingredient compound of Jianerqingjie solution and the control method |
| 09/26/2007 | CN101040935A Dropping pills agent for removing phlegm and relieving asthma and cough and the preparing method |
| 09/26/2007 | CN101040928A Treatment type ganoerma lucidum compound tea |
| 09/26/2007 | CN101040915A Method for preparing a Shuanhuanglian injection and the component detecting method |
| 09/26/2007 | CN101040898A Diphtheritic powder |
| 09/26/2007 | CN101040894A Preparing and application of Yulangsan extract |
| 09/26/2007 | CN101040650A Health-care type ganoderma lucidum combined tea |
| 09/26/2007 | CN101040641A Thin leaf chrysanthemum tea |
| 09/26/2007 | CN101040640A Tea for treating fever and cough |
| 09/26/2007 | CN100339391C Coronavirus (SARS-CoV)B-cell antigen determinate cluster with extensive cross immune activity |
| 09/26/2007 | CN100339390C Coronavirus specific T-cellantigen determinate cluster |
| 09/26/2007 | CN100339133C Composition of nanometer SOD and astragalus root or its extract and its preparation method |
| 09/26/2007 | CN100339130C 疫苗 Vaccine |
| 09/26/2007 | CN100339127C Development of an anti-cough, anti-tussive and throat soothing herbal formulation |
| 09/26/2007 | CN100339116C Saline buccal tablet for clearing and moistening throat |
| 09/26/2007 | CN100339115C Throat clearing and moistening sugar buccal tablet |
| 09/26/2007 | CN100339079C Substituted imidazolidines, process for their preparation, and their use as a medicament or diagnostic, and medicament comprising them |
| 09/26/2007 | CN100339077C New use of indole derivatives as anti-SARS medicine |
| 09/25/2007 | US7273875 Blocking tumor necrosis factor; antiinflammatory agents; respiratory system disorders; bronchodilator |
| 09/25/2007 | US7273872 alpha 7 receptor is the alpha -bungarotoxin sensitive receptor that influences the release of proinflammatory cytokines from macrophages |
| 09/25/2007 | US7273858 Salts |
| 09/25/2007 | US7273856 Antagonist of tachykinins like neurokinins and drugs |
| 09/25/2007 | US7273744 Heparanase-like polypeptides |
| 09/24/2007 | CA2571933A1 A descarbonylethoxyloratadine containing pharmaceutical composition |
| 09/20/2007 | WO2007106525A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 09/20/2007 | WO2007106034A1 New method for the manufacture of therapeutic compounds and compositions, compounds and compositions produced therewhith, and their use |
| 09/20/2007 | WO2007106022A2 A new crystalline form g of (5s) -5- [4- (5-chloro-pyridin-2- yloxy) -piperidine-1-sulfonylmethyl] - 5 -methyl -imidazolidine - 2,4-dione (i) and intermediates thereof. |
| 09/20/2007 | WO2007106016A1 Bezothiazol derivatives as beta2 adrenoreceptor agonists |
| 09/20/2007 | WO2007105945A2 Use of non-digestable sacharides for giving an infant the best start after birth |
| 09/20/2007 | WO2007105910A1 A pharmaceutical composition for the treatment of allergic diseases and chronic inflammatory diseases, and a method for treatment of allergic diseases and chronic inflammatory diseases |
| 09/20/2007 | WO2007105637A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
| 09/20/2007 | WO2007105053A2 Tetralines antagonists of the h-3 receptor |
| 09/20/2007 | WO2007104985A1 Compositions comprising apocynin , ginkgo and ginger and uses thereo |
| 09/20/2007 | WO2007104242A1 Compounds capable of inhibiting zinc ion metalloproteinases |
| 09/20/2007 | WO2007104070A1 Method and composition for treating allergic diseases |
| 09/20/2007 | WO2007071396A8 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
| 09/20/2007 | WO2007063311A3 Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 09/20/2007 | WO2007063308A3 Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 09/20/2007 | WO2007036743A3 Quinolines and their therapeutic use |
| 09/20/2007 | WO2005019190A3 (4 -amino -1,2, 5-oxadiazol-4-yl) -hetξroaromatic compounds useful as protein kinase inhibitors |
| 09/20/2007 | US20070219232 Chemical Compounds |
| 09/20/2007 | US20070219217 Triazolone Derivatives as Mmp Inhibitors for the Treatment of Asthma and Copd |
| 09/20/2007 | US20070219215 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both |
| 09/20/2007 | US20070219180 Muscle Relaxtion Accelerator and Therapeutic Agent for Muscular Tissue Diseases Such as Muscle Relaxation Failure |
| 09/20/2007 | US20070218003 Truncated Dance, Dance Complex And Method Of Using These |
| 09/20/2007 | CA2646154A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 09/20/2007 | CA2645472A1 Use of non-digestable saccharides for giving an infant the best start after birth |
| 09/20/2007 | CA2644368A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
| 09/20/2007 | CA2644345A1 A new crystalline form g of (5s) -5- [4- (5-chloro-pyridin-2- yloxy) -piperidine-1-sulfonylmethyl] - 5 -methyl -imidazolidine - 2,4-dione (i) and intermediates thereof. |
| 09/20/2007 | CA2644014A1 Bezothiazol derivatives as beta2 adrenoreceptor agonists |
| 09/20/2007 | CA2643055A1 Tetralines antagonists of the h-3 receptor |
| 09/19/2007 | EP1834960A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 09/19/2007 | EP1834953A1 Tetrahydropyrane derivatives as 5-lipoxygenase inhibitors |
| 09/19/2007 | EP1834947A2 3-substituted amino-1H-indole-2-carboxylic acid and 3-substituted amino-benzo[B]thiophene-2carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 09/19/2007 | EP1834643A2 Novel medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients |
| 09/19/2007 | EP1833840A2 Potent lna oligonucleotides for the inhibition of hif-1a |
| 09/19/2007 | EP1833834A1 New compounds |
| 09/19/2007 | EP1833832A1 Napthyridine compounds as rock inhibitors |
| 09/19/2007 | EP1833503A2 Pulmonary surfactant formulations |
| 09/19/2007 | EP1833502A1 Pharmaceutical composition for the treatment of invasive pulmonary aspergillosis |
| 09/19/2007 | EP1833487A1 New use of gabab receptor agonists |
| 09/19/2007 | EP1833313A2 Compositions containing high omega-3 and low saturated fatty acid levels |
| 09/19/2007 | EP1515975B1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 09/19/2007 | EP1499605B1 NF-KappaB INHIBITORS |
| 09/19/2007 | EP1439841B1 Androgen receptor modulators and methods of use thereof |
| 09/19/2007 | EP1333819B1 Inhalative solution formulation containing a tiotropium salt |